LOXO Shares Outstanding History



Below is a table of the LOXO shares outstanding history going back to 8/1/2014:

Date LOXO Shares Outstanding
8/1/201415.06M
9/12/201416.63M
11/11/201416.63M
2/28/201516.63M
5/1/201516.69M
7/31/201516.69M
10/31/201516.69M
2/29/201619.65M
4/30/201619.71M
7/31/201621.66M
10/31/201621.68M
2/28/201726.15M
4/30/201726.15M
7/31/201729.85M
10/31/201729.94M
2/23/201830.03M
4/30/201830.08M
7/31/201830.47M
10/31/201830.61M

Also see: LOXO Market Cap History
LOXO YTD Return
LOXO Historical Shares Outstanding:
+18.15% CAGR
LOXO Historical Shares Outstanding: +18.15% CAGR

Mouse over chart for data details
8/1/2014 ...10/31/2018
Loxo Oncology is a biopharmaceutical company engaged in the development of selective medicines for patients with genetically defined cancers. Co.'s main product candidate is Larotrectinib, an oral, selective inhibitor of the tropomyosin receptor kinase (TRK) family in development for the treatment of tumors with TRK fusions. Co.'s drug candidate, LOXO-195 is designed as a second-generation TRK inhibitor intended to address predicted acquired resistance mechanisms resulting from therapy with a first-generation TRK inhibitor such larotrectinib, or multikinase inhibitors with anti-TRK activity. Co.'s LOXO-292 targets a cancer oncogene known as Rearranged during Transfection. We show 19 historical shares outstanding datapoints in our coverage of LOXO's shares outstanding history.

Understanding the changing numbers of LOXO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LOXO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LOXO by allowing them to research LOXO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LOXO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Loxo Oncology (LOXO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

LPCN Shares Outstanding History
LPNT Shares Outstanding History
LPTX Shares Outstanding History
LQDA Shares Outstanding History
LRMR Shares Outstanding History
LSTA Shares Outstanding History
LTRN Shares Outstanding History
LUCD Shares Outstanding History
LUMO Shares Outstanding History
LUNG Shares Outstanding History
More Healthcare companies »

 

LOXO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.